CoreCap Advisors LLC Sells 7,804 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

CoreCap Advisors LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 77.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,314 shares of the medical equipment provider's stock after selling 7,804 shares during the period. CoreCap Advisors LLC's holdings in Intuitive Surgical were worth $1,208,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $26,000. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the 4th quarter worth $28,000. Finally, Hurley Capital LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at about $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the company's stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company's stock, valued at $208,181.75. This represents a 53.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company's stock, valued at $271,397.94. This represents a 63.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,044 shares of company stock valued at $17,070,433. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $24.92 on Monday, hitting $561.43. The company had a trading volume of 2,036,477 shares, compared to its average volume of 1,633,304. Intuitive Surgical, Inc. has a 52 week low of $379.67 and a 52 week high of $616.00. The company has a market cap of $201.23 billion, a PE ratio of 87.59, a PEG ratio of 5.85 and a beta of 1.70. The business has a 50-day simple moving average of $500.93 and a 200-day simple moving average of $535.03.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the firm posted $1.50 EPS. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on ISRG shares. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Barclays dropped their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Finally, Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.